Clinical Trial Update: Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sequential GEMBRAX followed by FOLFIRINOX and then stereotactic MRI-guided radiotherapy for locally advanced pancreatic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• FOLFIRINOX
• Gembrax

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING